Washington 2025-2026 Regular Session

Washington Senate Bill SB5696

Introduced
2/7/25  
Refer
2/7/25  
Report Pass
2/27/25  
Engrossed
3/5/25  
Refer
3/7/25  
Report Pass
3/27/25  
Refer
3/31/25  
Enrolled
4/17/25  
Chaptered
4/22/25  

Caption

AN ACT Relating to the sales and use tax supporting chemical dependency and mental health treatment programs;

Impact

The introduction of SB5696 is projected to have a significant impact on state laws governing taxation and healthcare funding. By allocating sales and use tax revenues towards mental health and chemical dependency services, the bill potentially redirects financial resources to areas that historically have been underfunded. This shift could result in improved access to treatment for individuals affected by addiction and mental health issues, fostering a more supportive societal framework in response to these challenges.

Summary

SB5696 is a legislative measure focused on supporting chemical dependency and mental health treatment programs through revenue generated from sales and use taxes. The bill aims to address pressing issues related to mental health and addiction by ensuring that adequate funding is available for necessary treatments and support services. It seeks to leverage existing tax structures to provide a sustainable funding source, ultimately enhancing the quality of care available to individuals suffering from these conditions.

Sentiment

General sentiment towards SB5696 seems to be cautiously optimistic among proponents who recognize the importance of addressing mental health and addiction issues. Supporters believe that the bill's funding mechanisms will allow for more comprehensive and effective treatment options. However, some skepticism exists regarding the adequacy of sales and use tax as a sustainable source of funding, with concerns about the potential fluctuations in tax revenue impacting the stability of funding for treatment programs.

Contention

Notable points of contention surrounding SB5696 include debates around the effectiveness of relying solely on sales and use tax to fund mental health services. Critics argue that this approach may not be sufficient to meet the growing demands for care, particularly in economically challenged areas where such taxes may generate less revenue. Additionally, discussions may arise regarding the prioritization of funds and whether there are better funding solutions available to support mental health and chemical dependency initiatives.

Companion Bills

No companion bills found.

Previously Filed As

WA HB2279

Evaluating the use of PFAS chemicals in agriculture.

WA SB5033

AN ACT Relating to sampling or testing of biosolids for PFAS chemicals;

WA HB2429

AN ACT Relating to supporting children and youth behavioral health;

WA HB2194

Concerning sales and use tax for cultural access programs.

WA SB6224

Supporting children and youth behavioral health.

WA LB330

Change provisions relating to the sales tax rate and create the Alcohol Addiction Prevention and Treatment Fund

WA SB5617

Revised for 1st substitute: Supporting juveniles in and exiting detention by providing for a child in need of services process and supportive services.

WA SB5988

AN ACT Relating to establishing fee authority for accreditation services provided to opioid treatment programs by the department of health;

WA HB2008

AN ACT Relating to chemicals in certain personal hygiene products, including menstrual products and diapers;

WA HB1805

Creating a local sales and use tax to fund services for children and families that enhance well-being, promote mental health, and provide early interventions.

Similar Bills

No similar bills found.